Certuity’s Pfizer PFE Stock Holding History

Certuity’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-316	Closed	-$11K	–	267
2020 Q3	$11K	Buy	+316	New	+$11.1K	﹤0.01%	201
2020 Q2	–	Sell	-1,054	Closed	-$33K	–	209
2020 Q1	$33K	Buy	+1,054	New	+$35.9K	0.02%	169

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Certuity's PFE Position: Q2 2026 in Review

Certuity increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $53.1K and bringing the position to 150,075 shares worth $3.61M. The position accounts for 0.18% of the portfolio, ranked #76.

Certuity first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.16M in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Certuity held 150,075 shares of Pfizer worth $3.61M as of Q2 2026.
Certuity bought 2,030 Pfizer shares in Q2 2026, an estimated $53.1K.
Pfizer made up 0.18% of Certuity's portfolio in Q2 2026, its #76 holding.
Certuity first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
Certuity's Pfizer position peaked at $4.16M in Q1 2026.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.